The AIDS Support Organization (TASO) Soroti Region Project, Soroti, Uganda.
Tokora Health Centre IV, Nakapiripirit District, Uganda.
BMJ Open Qual. 2023 Aug;12(3). doi: 10.1136/bmjoq-2023-002314.
People with bacteriologically confirmed pulmonary tuberculosis (BC-PTB) require sputum smear monitoring (SSM) to ascertain response to anti-TB treatment and cure from TB disease. We aimed to increase SSM at 2, 5 and 6 months among people with BC-PTB from the baseline (March to July 2021) of 68%, 37% and 39%, respectively, to 90% in February 2022 by implementing a context-specific improvement package at a rural health facility in northeastern Uganda.
We designed a continuous quality improvement (CQI) study for people with BC-PTB, developed and tested an improvement package that consisted of the following context-specific measures: (1) line listing of all eligible persons for SSM; (2) use of reminder stickers to identify eligible persons for SSM; (3) use of community health workers to conduct home visits for people with missed clinic visits; and (4) integration of SSM into community-based ART points for distant persons. We implemented the measures using the plan-do-study-act cycle and tracked the progress in SSM through monthly data reviews and analyses.
SSM at 2 months improved from 68% (17/25) at the baseline to 74% (32/43) during phase I (p=0.818) and then to 94% (17/18) during phase II (p=0.562). SSM at 5 months improved from 37% (11/29) at the baseline to 82% (41/50) during phase I (p=0.094) and then to 100% (10/10) during phase II (p=0.688). SSM at 6 months improved from 39% (9/23) at the baseline to 59% (28/39) during phase I (p=0.189) and then to 100% (12/12) during phase II (p=0.487).
The use of a context-relevant CQI package was accompanied by improved SSM at 2, 5 and 6 months among people with BC-PTB. Trends are encouraging but this should be considered as preliminary report because of limited numbers. These data can inform the design of a fully powered randomised controlled trial.
经细菌学证实患有肺结核(BC-PTB)的患者需要进行痰涂片监测(SSM),以确定对抗结核治疗的反应和结核病的治愈情况。我们的目标是通过在乌干达东北部的农村卫生机构实施特定于背景的改进方案,将 2、5 和 6 个月时的 SSM 从基线(2021 年 3 月至 7 月)的 68%、37%和 39%分别提高到 2022 年 2 月的 90%。
我们为 BC-PTB 患者设计了一项持续质量改进(CQI)研究,开发并测试了一个改进方案,其中包括以下特定于背景的措施:(1)列出所有符合 SSM 条件的人员名单;(2)使用提醒贴纸来识别符合 SSM 条件的人员;(3)利用社区卫生工作者对错过诊所就诊的人员进行家访;(4)将 SSM 纳入社区艾滋病病毒治疗点,为偏远地区的人员提供服务。我们使用计划-执行-研究-行动(PDSA)循环实施这些措施,并通过每月的数据审查和分析来跟踪 SSM 的进展情况。
2 个月时的 SSM 从基线的 68%(17/25)提高到第 I 阶段的 74%(32/43)(p=0.818),然后提高到第 II 阶段的 94%(17/18)(p=0.562)。5 个月时的 SSM 从基线的 37%(11/29)提高到第 I 阶段的 82%(41/50)(p=0.094),然后提高到第 II 阶段的 100%(10/10)(p=0.688)。6 个月时的 SSM 从基线的 39%(9/23)提高到第 I 阶段的 59%(28/39)(p=0.189),然后提高到第 II 阶段的 100%(12/12)(p=0.487)。
使用与背景相关的 CQI 方案伴随着 2、5 和 6 个月时 BC-PTB 患者的 SSM 提高。趋势令人鼓舞,但由于数量有限,这应被视为初步报告。这些数据可以为设计一项完全随机对照试验提供信息。